Ann: Appendix 4C - Quarterly Report & Company Update - March 2017, page-16

I have very limited knowledge on the medical side but do have a few contacts that understand the medical production side and my understanding is that moving to a powder for the medication makes it a more stable product and better shelf life then in gel capsules or the liquid before it.

I have not read any where that they were shifting to the powder formula for palatibility reasons which is what I took from Captains post but I could have just mis understood, so that is what I wanted to know about in case I had missed it as still having this issue would be worrying with Ph2 underway.

It would not surprise me in the least that this is just the next phase in development but as per this Companies track record they have not felt the need to promote these steps. Which just comes back to the same old issue of comm's and marketing.

Happy to be corrected on any of this.